Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions
Active Filters (1)
Clear All
241 - 250 of 250 Results
Sort by:
Best Match

Understanding the anti-inflammatory effects of a microbiota-derived metabolite using high-content analysis and AlphaLISA
Here we combine HCA and AlphaLISA cytokine detection to further characterize the anti-inflammatory effect of UroA on LPS-stimulated human macrophage-like cells.

Homogeneous detection of cytokines from PBMC supernatants using AlphaLISA High Performance assays
Learn how to easily detect and quantify cytokines with a homogenous immunoassay in this step-by-step

Download your guide about neurodegenerative diseases
Emerging pathways to neuroinflammation and neurodegeneration

Best practices to measure cytokines in whole blood with AlphaLISA
Streamline your cytokine detection with no-wash assays, while overcoming the typical challenges associated with whole blood samples.

Biochemical binding ADCC assays utilizing AlphaLISA toolbox reagents for the characterization of hIgGs and FcγR1A
In this application note we demonstrate the ease with which AlphaLISA toolbox reagents can be used to develop any FcγR binding assay across the various stages of biologics research and development, including therapeutic screening and GMP Lot Release.

Pooled functional genomic screening brochure
Functional genomic screening has the potential to reshape drug discovery, enhance our understanding of biological systems, and revolutionize personalized medicine.

CRISPR workflow solutions brochure
This brochure details the different CRISPR screening methods, including pooled and arrayed screens, and highlights various CRISPR applications such as disease modeling, pathway analysis, target identification, and cell and gene therapy.

A fast and simple chemiluminescent assay for monitoring of DNA-protein interactions
In this application note, we use HepG2 nuclear extracts to demonstrate the binding of Sp1 and HNF1 transcription factors to tagged oligonucleotides containing required cognate response elements. Read this note to see the results and access detailed data compared to EMSA.

No-wash cytokine assay solutions
Learn about our full range of no-wash cytokine assays, enabling your research and ability to easily detect and quantify cytokines.

Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases
Traditional treatments for neurodegenerative diseases focus on managing symptoms, but recent advancements in gene therapy offer hope for more effective and sustainable solutions. Read now!


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.